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on–ST-Segment Elevation
yocardial Infarction Treated
t Hospitals With and Without
n-Site Cardiac Surgery
hat Is the Important Point?*
regory J. Dehmer, MD,†
alph G. Brindis, MD, MPH‡
emple, Texas; and Oakland, California
he title of the report by Pride et al. (1) in this issue of
ACC: Cardiovascular Interventions, suggests this is another
ontribution to the debate about the safety of percutaneous
oronary interventions (PCI) performed at hospitals with-
ut cardiac surgery on-site (No-OHS). That issue is ad-
ressed, but in reality this report relates more to the benefits
f using evidence-based therapies in patients with non–ST-
egment elevation myocardial infarction (NSTEMI).
See page 944
The debate about PCI at No-OHS facilities in the U.S.
s not new. Based on the superior outcomes of PCI in
atients with ST-segment elevation myocardial infarction
STEMI), some hospitals with diagnostic catheterization
aboratories, but No-OHS, started PCI programs to provide
his care to their local communities (2). Because it is difficult
o sustain a PCI program solely on STEMI patients, these
rograms expanded to elective PCI (3). However, debate
ontinued as the 2005 PCI guidelines recommended that
lective PCI without surgery on-site not be performed (4).
n 2007, an expert consensus document provided a compre-
ensive review of PCI without on-site surgery and con-
ained survey data showing that elective PCI without
n-site surgery was being performed in 28 states despite
uideline recommendations (5). Recently, data from the
CDR (National Cardiovascular Data Registry) reaffirmed
he safety of PCI without on-site surgery as did an update
rom the Mayo Clinic experience (6,7). Nevertheless, PCI
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-
ions or the American College of Cardiology.
From the †Cardiology Division, Texas A&M University Health Science Centers
ollege of Medicine and Scott & White Healthcare, Temple, Texas; and the ‡Kaiser
ermanente Health System, Oakland, California.ithout on-site surgery remains a polarizing and emotional
ssue for many individuals.
The more important message of this study, however,
erives from their data showing how the use of evidence-
ased therapies affects outcomes. Developing strategies to
chieve the best outcomes, enhance patient safety, and
mprove the quality of care have moved to the forefront of
any discussions about health care reform. Several studies
how that improved adherence to guidelines results in better
utcomes (8,9). Although debate has focused on whether
CI should be allowed at No-OHS facilities, a more
eaningful approach would focus on the goal of providing
he best care possible to patients regardless of the setting.
The report by Pride et al. (1) provides indirect support
hat adherence to guideline recommendations improves
utcomes. The authors identified approximately 100,000
atients from the NRMI (National Registry of Myocardial
nfarction) database who presented with NSTEMI. Pa-
ients at hospitals with open heart surgery (OHS) were
ompared with patients who presented to No-OHS hospi-
als. Three separate analyses were performed with the end
oints of in-hospital mortality: recurrent myocardial infarc-
ion (MI); the composite of death and MI; and the
omposite of death, MI, congestive heart failure, and
ardiogenic shock.
In the first analysis, the entire cohort was compared.
lthough the numerical differences were small, patients at
HS hospitals were more likely to receive aspirin, beta-
lockers, and statins within the first 24 h and were more
ikely to undergo coronary angiography and PCI than their
ounterparts at No-OHS hospitals. In-hospital mortality
nd the 2 composite end points were lower while the use of
uideline-recommended medications at discharge was
igher at OHS hospitals.
In the second comparison, patients at No-OHS hospitals
ere propensity-matched to patients at OHS hospitals
sing 15 clinical factors. The numerical differences in
edication use between the groups during the first 24 h
ere smaller, but still favored a higher use of guideline-
ecommended drugs at OHS hospitals. Patients at OHS
ospitals were more likely to receive angiography and PCI
nd also were less likely to be transferred to a different
ospital (2.7% vs. 35.4%). This is an important caveat as
ransferred out patients were subsequently excluded from
he outcome analyses. In this analysis, patients presenting to
HS facilities had lower in-hospital mortality and a lower
ncidence of the composite of death and MI compared with
hose at No-OHS hospitals, but the other end points were
ot different. Patients discharged from OHS hospitals
emained more likely to go home with aspirin, beta-
lockers, and statins. However, when this cohort was
urther matched for hospital characteristics and annual MI
olume, the mortality advantage at OHS hospitals was
maller and borderline significant (p  0.05).
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954It is important to emphasize the limitations of these
onclusions, some of which are acknowledged by the au-
hors. NRMI data are unaudited, thus the accuracy of data
ntry could vary between small and larger centers. Hospitals
articipating in the NRMI may not be representative of all
acilities involved in acute MI care, and follow-up beyond
ischarge was not available. However, the major weakness
f the study relates to the issue of patients transferred into
nd out of facilities. Patients transferred into a facility were
onsidered in the analysis. OHS hospitals had a transfer-in
ate of 34.8% versus only 5.8% for No-OHS hospitals. This
ikely reflects physician bias in decisions about whether to
ransfer the patient at all, or if transferred what type of
acility to be the recipient. Patients transferred from a
on–PCI- to a PCI-capable hospital were likely considered
ood candidates for angiography and possible revasculariza-
ion whereas those felt to be poor candidates would likely
ot be transferred. A more serious bias relates to patients
ransferred out from No-OHS hospitals as they were
xcluded from the analysis. About 35% of the roughly 6,000
atients admitted to No-OHS hospitals were transferred to
nother facility, but the reasons for transfer were never
isclosed. Since only hospitals with PCI capability were
ncluded in this part of the analysis, it could be assumed that
atients transferred out from a No-OHS facility were
udged “too sick” to undergo angiography at that hospital or
fter angiography were felt too “high risk” for PCI at a
o-OHS facility. This further clouds the interpretation of
hese data.
In the final analysis, the propensity-matched cohort
as further restricted to the 1,282 patients in each group
ho underwent PCI. Based on a comparison of clinical
actors, patients undergoing PCI were a lower risk group
han the entire study cohort. In contrast to the other
nalyses, patients at No-OHS hospitals were either more
r equally likely to receive guideline-recommended drug
herapies within the first 24 h. In-hospital mortality, the
composite end points, and the administration of
uideline-recommended discharge medications were now
imilar among hospitals, but recurrent MI was higher at
HS hospitals.
From this, the authors developed 2 main conclusions.
irst, patients with NSTEMI who present to No-OHS
ospitals have higher in-hospital mortality even after ad-
usting for differences in baseline characteristics. However,
hen adjusting for the use of guideline-recommended
edications within the first 24 h, mortality was reduced
hazard ratio: 0.70 to 0.81, p  0.001). Although indirect,
he message is better adherence to guideline-recommended
edications is associated with reduced mortality. Believing
hat better adherence to guideline recommendations im-
roves outcomes seems intuitive, but recently the guideline
evelopment process has come under scrutiny (10). Al-
hough improving how guidelines are developed is appro-riate, there is evidence that existing guidelines enhance
atient outcomes (8,9,11,12). A recent study examining
oronary artery bypass surgery concluded that maximizing
dherence to 6 quality measures improved overall mortality
ates and equalized mortality rates even for surgeons and
acilities in the lowest quartile of case volumes (13).
Second, there was no difference in mortality among the
atched NSTEMI patients who underwent PCI at hospi-
als with and without OHS. This will bolster the argument
hat performing PCI without on-site surgery is safe, but it is
mportant to remember the many statistical adjustments
sed in this study and their limitations. It is the responsi-
ility of physicians performing PCI at facilities with No-
HS to follow strict screening criteria to ensure only lower
isk elective cases are performed at such facilities (5). In this
tudy, patients undergoing PCI at OHS hospitals had a
igher incidence of recurrent MI. Since the NRMI only
ncluded in-hospital outcomes, the recurrent MIs were
ikely procedure-related thus suggesting the transfer of
igher-risk PCIs from No-OHS to OHS hospitals had
ccurred.
In addition to providing information on safety at hospi-
als without surgery on-site, the more compelling message
rom this report relates to the importance of guideline
dherence and promoting quality in the management of
atients with NSTEMI. Healthcare reform is on everyone’s
ind, and how this will be accomplished is still unknown.
owever, it is apparent that there will be a strong emphasis
n improving quality, and it is likely that payments will be,
n some fashion, linked to meeting performance measures
nd quality metrics. All effective, evidence-based therapies,
egardless of where a patient is treated and irrespective of
hether the treatment is revascularization or medical ther-
py alone, should be implemented and monitored to ensure
ptimal outcomes for all patients with NSTEMI.
eprint requests and correspondence: Dr. Gregory J. Dehmer,
exas A&M University, College of Medicine, Cardiology Divi-
ion, Scott & White Healthcare, 2401 South 31st Street, Temple,
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